Clinical Trial Update: Improved Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Protocol for the Treatment of Epstein Barr Virus T/NK Lymphoproliferative Disease (EBV-T/NK LPD) and Prevention of Post Transplant Graft-versus-host Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial updating a myeloablative allogeneic stem cell transplant protocol to treat Epstein-Barr virus T/NK lymphoproliferative disease and to pre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epstein-barr Virus Nk Lymphoproliferative Disease

Snippet

Sponsor: Beijing Children's Hospital | Conditions: EBV-T/NK LPD | Phase 4 | Status: RECRUITING